Blood Glucose Meter Market to Rise at 9.6% CAGR and Hit USD 15,415.6 Million by 2026; Driven by Rising Uptake of Non-Invasive Meters, says Fortune Business Insights™

Key Companies Covered in the Blood Glucose Meter Market Research Report Are F. Hoffmann-La Roche Ltd, Dexcom, Inc., B. Braun Melsungen AG, Medtronic, Lifespan Inc., Ascensia Diabetes Care Holdings AG., Terumo Medical Corporation, Abbott, Sanofi, DiaMonTech GmbH. and other key market players.


Pune, India, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The global Blood Glucose Meter Market size is likely to expand considerably in the coming years due to advent of non-invasive devices. According to a report published by Fortune Business Insights, titled “Blood Glucose Meters: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,419.0 Mn in 2018. Fortune Business Insights states that this market is likely to reach US$ 15,415.6 Mn by 2026, thereby exhibiting a CAGR of 9.6%.

Key Industry Developments

  • In June 2018, BioTel CareTM, introduced next-generation wireless blood glucose monitor for diabetes management. It is the first FDA-cleared, cellular-enabled glucometer which supports real-time transmission and consolidation of patient data in an FDA-cleared cloud.
  • In June 2018, OK Biotech Co., Ltd., launched new portable blood glucose meter model. It is a new compact glucose meter, and a non-invasive glucose meter.
  • In August 2017, ARKRAY USA, Inc., announced launch of the GLUCOCARD Shine XL blood glucose monitoring system. GLUCOCARD Shine XL BGMS offers an ergonomic designed meter to provide a secure grip during testing and displays the results on the large LED screen.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/blood-glucose-meters-market-100770


Launch of DiaMonTech’s IR-based Blood Glucose Meter to Spur Growth Opportunities

Conventional blood glucose meters involved the need for invasive techniques for diagnosis. The most commonly used methods involved taking blood samples with the help of needle pricks in fingers. The needle prick method was painful for many users and it caused discomfort to some.

Therefore, there has been a constant need for an alternative to the invasive devices for continuous glucose monitoring. In 2018, DiaMonTech announced the launch of a compact blood glucose meter. The device performed on an infra-red technology that is used to count the glucose molecules.

This product is likely to transform existing blood glucose monitoring techniques and is likely to witness high demand from around the world. The advent of non-invasive devices is likely to induce growth in the global Blood Glucose Meter Market.


Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/blood-glucose-meters-market-100770


LifeScan and Sanvita Medical Collaborate to Develop Continuous Glucose Monitoring Devices

In May 2019, LifeScan announced that it has reached an agreement with Sanvita Medical for development and marketing of continuous glucose monitoring (CGM) devices. Through this agreement, the company aims at making CGM devices available throughout North America and certain parts of Europe in initial years, with an aim of expanding in other parts of the world in the coming years.

The company boasts an attractive product portfolio and its latest addition of CGM devices will bode well for the future business expansion. This partnership will have a positive impact on the global market and is likely to favor growth of the market in the coming years.


Quick Buy -  Blood Glucose Meter Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100770


Abbott’s Freestyle Libre Flash Glucose Monitoring Device Receives FDA Approval

In 2017, Abbott received clearance from the Food and Drug Administration for its Libre Flash device. The device was approved for patients with type 1 and type 2 diabetes, after a series of successful clinical trials.

The blood glucose meter’s accuracy is expected to result in huge demand in the coming years. Abbott’s latest device is likely to bolster growth of the global Blood Glucose Meter Market and is likely to favor growth of the market in the forthcoming years.


List of the leading companies operating in the global Blood Glucose Meter Market:

  • F. Hoffmann-La Roche Ltd
  • Dexcom, Inc.
  • B. Braun Melsungen AG
  • Medtronic
  • Lifespan Inc.
  • Ascensia Diabetes Care Holdings AG.
  • Terumo Medical Corporation
  • Abbott
  • Sanofi
  • DiaMonTech GmbH
  • Other players


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/blood-glucose-meters-market-100770


Global Blood Glucose Meter Market Segmentation:

By Product           

•              Continuous Glucose Monitoring Devices

•              Self-Monitoring Blood Glucose (SMBG) Systems

By Technique       

•              Invasive

•              Non-Invasive

By Type 

•              Wearable

•              Non-Wearable

By Distribution Channel    

•              Institutional Sales

o              Hospitals

o              Clinics

o              Others

•              Retail Sales

o              Hospital Pharmacies

o              Retail Pharmacies

o              Online Pharmacies

By Geography      

•              North America (USA and Canada)

•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

•              Latin America (Brazil, Mexico and Rest of Latin America)

•              Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/blood-glucose-meters-market-100770


SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:

  • Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
  • Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
  • Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
  • Number of procedures and average price of procedures
  • Replacement rate and pricing of capital equipment
  • Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
  • Market & technological trends, new product developments, product pipeline.


Have a Look at Related Reports:

Diabetic Foot Ulcer (DFU) Treatment Market Share & Industry Analysis, By Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-ischemic Ulcer), By Product (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2019-2026

Diabetes Monitoring Devices Market Share and Global Trend by Product (Blood Glucose Meters, Test Strips, Lancets), Distribution Channel (Institutional Sales, Retail Sales) & Geography Forecast till 2026

Diabetes Drugs Market Share and Global Trend By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors), Diabetes Type (Type 1, Type 2), Route of Administration (Oral, Subcutaneous, Intravenous), Distribution Channel (Online pharmacies, Hospital Pharmacies, Retail Pharmacies) & Geography Forecast till 2026

Diabetes Treatment Devices Market Share and Global Trend By Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales (Hospitals, Clinics), Retail Sales (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)) & Geography Forecast till 2026

Diabetes Devices Market Share and Global Trend By Product (Monitoring Devices, Treatment Devices), By Distribution Channel (Institutional Sales, Retail Sales) and Geography Forecast till 2026


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.


Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs


Press Release: https://www.fortunebusinessinsights.com/press-release/blood-glucose-meters-market-9150